Takeda Gets FDA Label Expansion for HyQvia in Rare Autoimmune Disorder

Submitted by admin on January 17, 2024 - 8:27pm

Source:

BioSpace

News Tags:

Takeda

FDA

HyQvia

demyelinating polyneuropathy

Headline:

Takeda Gets FDA Label Expansion for HyQvia in Rare Autoimmune Disorder

snippet:

The FDA on Tuesday approved the use of Takeda’s HyQvia (immune globulin infusion 10% with recombinant human hyaluronidase) as a treatment for chronic inflammatory demyelinating polyneuropathy.

Search form

You are here

Takeda Gets FDA Label Expansion for HyQvia in Rare Autoimmune Disorder

Takeda Gets FDA Label Expansion for HyQvia in Rare Autoimmune Disorder